Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma.

Journal of clinical pathology - 1 Sept 2012

Liu Dingsheng, Lin Pei, Hu Ying, Zhou Yi, Tang Guilin, Powers Linda, Medeiros L Jeffrey, Jorgensen Jeffrey L, Wang Sa A

Abstract excerpt

Plasma cell myeloma (PCM) exhibits immunophenotypic aberrancies that can be used for minimal residual disease (MRD) detection after therapy. The authors sought to determine whether non-neoplastic plasma cells, especially in the bone marrow (BM) post various therapies, would exhibit immunophenotypic variations interfering PCM MRD detection. The authors studied the flow cytometric immunophenotypes of non-neoplastic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD19
Share to Antigens, CD20

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Bone Marrow Examination

Share to CD28 Antigens

Share to Immunoglobulin kappa-Chains

Share to Leukocyte Common Antigens

Share to Neoplasm, Residual

Share to Plasma Cells

Source

Identifiers

PMID: 22685235
DOI: 10.1136/jclinpath-2012-200881

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma.PMID 22685235Read ↗

Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance.Semantic proximity Read ↗

Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myelomaSemantic proximity Read ↗

Multiple Myeloma: Heterogeneous in Every WaySemantic proximity Read ↗

[Research progress on multiple myeloma immunophenotyping and minimal residual disease detected by flow cytometry].Semantic proximity Read ↗

Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future PerspectivesSemantic proximity Read ↗

[B-cell neoplasms with plasmacellular and plasmablastic differentiation].Semantic proximity Read ↗

Minimal residual disease in multiple myeloma: defining the role of next generation sequencing and flow cytometry in routine diagnostic useSemantic proximity Read ↗

Clinical, Immunophenotypic, and Genetic Characterization of Small Lymphocyte–Like Plasma Cell MyelomaSemantic proximity Read ↗

Circulating plasma cells (either polyclonal or monoclonal) as markers of aggressive Multiple Myeloma phenotypeSemantic proximity Read ↗

Genetic Abnormalities and Patterns of Antigenic Expression in Multiple MyelomaSemantic proximity Read ↗

Towards Stratified Medicine in Plasma Cell Myeloma.Semantic proximity Read ↗

Genotypic identification of polyclonal plasma cells in plasma cell dyscrasias shows an aberrant single-cell phenotype with clinical implicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.